Tsianakas, Athanasios <br/><br/>
Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU).  [electronic resource] 

 -  Acta dermato-venereologica  Apr 2019 
 - 379-385 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1651-2057 
<br/><br/><label>Standard No.: </label>10.2340/00015555-3120  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antipruritics--adverse effects<br/>Aprepitant--adverse effects<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Drug Resistance<br/>Female<br/>Germany<br/>Histamine Antagonists--therapeutic use<br/>Humans<br/>Male<br/>Middle Aged<br/>Neurokinin-1 Receptor Antagonists--adverse effects<br/>Prurigo--diagnosis<br/>Quality of Life<br/>Severity of Illness Index<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult